| Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications MN Huda, M Nafiujjaman, IG Deaguero, J Okonkwo, ML Hill, T Kim, ... ACS biomaterials science & engineering 7 (6), 2106-2149, 2021 | 178 | 2021 |
| Potential application of exosomes in vaccine development and delivery MN Huda, M Nurunnabi Pharmaceutical Research 39 (11), 2635-2671, 2022 | 43 | 2022 |
| Nano-vesicle based anti-fungal formulation shows higher stability, skin diffusion, biosafety and anti-fungal efficacy in vitro IG Deaguero, MN Huda, V Rodriguez, J Zicari, TA Al-Hilal, ... Pharmaceutics 12 (6), 516, 2020 | 23 | 2020 |
| Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma MN Huda, IG Deaguero, EA Borrego, R Kumar, T Islam, H Afrin, ... Journal of Controlled Release 349, 783-795, 2022 | 20 | 2022 |
| Theoretical and experimental insights into the possible interfacial interactions between β-Glucan and fat molecules in aqueous media T Islam, MN Huda, MA Ahsan, H Afrin, C Joseph J Salazar, M Nurunnabi The Journal of Physical Chemistry B 125 (50), 13730-13743, 2021 | 11 | 2021 |
| Detection of anticancer drug-induced cardiotoxicity using VCAM1-targeted nanoprobes H Afrin, MN Huda, T Islam, BP Oropeza, E Alvidrez, MI Abir, T Boland, ... ACS applied materials & interfaces 14 (33), 37566-37576, 2022 | 10 | 2022 |
| Topical administration of an apoptosis inducer mitigates bleomycin-induced skin fibrosis MN Huda, EA Borrego, CD Guerena, A Varela-Ramirez, RJ Aguilera, ... ACS Pharmacology & Translational Science 6 (5), 829-841, 2023 | 4 | 2023 |
| Carbon Coated Iron–Cobalt Nanoparticles for Magnetic Particle Imaging R Kumar, MN Huda, A Habib, M Nafiujjaman, HJ Woo, T Kim, ... ACS applied bio materials 6 (8), 3257-3265, 2023 | 1 | 2023 |
| Oral delivery compositions for obesity management M Nurunnabi, H Afrin, MN Huda, CJJ Salazar US Patent App. 17/871,953, 2023 | 1 | 2023 |
| Exosome-mediated bioinspired drug delivery MN Huda, JE Zicari, M Nurunnabi Bioinspired and Biomimetic Materials for Drug Delivery, 219-240, 2021 | 1 | 2021 |
| Topical Therapy of Skin Fibrosis and Melanoma M Nurunnabi, MN Huda US Patent App. 18/057,554, 2023 | | 2023 |
| Targeting Delivery of BCL-2 Family Protein Inhibitor Has the Potential to Treat Cancer and Fibrosis MN Huda The University of Texas at El Paso, 2022 | | 2022 |
| Noninvasive Detection of Cardiotoxicity Induced by Chemotherapeutic H Afrin, M Nurulhuda, T Islam, M Nurunnabi Circulation 144 (Suppl_1), A14302-A14302, 2021 | | 2021 |
Md NurunnabiUniversity of MississippiVerificeret mail på olemiss.edu